Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, double-blind, double dummy, multicentre phase III study comparing the efficacy of budesonide/formoterol (Symbicort (R) Forte Turbuhaler (R)) and oral prednisolone + formoterol (Oxis (R) Turbuhaler) during two weeks, in COPD [chronic obstructive pulmonary disease] patients with an acute exacerbation, followed by twelve weeks open follow up period with budesonide/formoterol (Symbicort Forte Turbuhaler)

Next Previous
X
Search
Trial Profile

A randomised, double-blind, double dummy, multicentre phase III study comparing the efficacy of budesonide/formoterol (Symbicort (R) Forte Turbuhaler (R)) and oral prednisolone + formoterol (Oxis (R) Turbuhaler) during two weeks, in COPD [chronic obstructive pulmonary disease] patients with an acute exacerbation, followed by twelve weeks open follow up period with budesonide/formoterol (Symbicort Forte Turbuhaler)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Formoterol; Prednisolone
  • Indications Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Acronyms SPACE
  • Sponsors AstraZeneca

    • Most Recent Events

    • 07 Oct 2008 Primary endpoint 'Forced expiratory volume in 1 second' has been met.
    • 07 Oct 2008 Results reported at Annual Congress of European Respiratory Scoiety.
    • 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top